EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome

Indira Garcia-Cordero, Juan Camilo Vargas-Gonzalez, Mohsen Hadian, Ece Bayram, Federico Rodriguez-Porcel, Blas Couto, Jay Iyer, Lawrence I Golbe, Christopher D Stephen, Alexander Pantelyat, Marian L Dale, Nikolaus McFarland und 9 weitere

Alzheimer's & Dementia · 2025-07 · 21 (7)

DOI: 10.1002/alz.70485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.07.2025. Verfasst von Indira Garcia-Cordero und 20 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Language Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Marion and Gerald Soloway Chair in Brain Injury and Concussion Research, Vivli, Inc, UCB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cognitive impairment is common but often overlooked due to motor symptoms in progressive supranuclear palsy‐Richardson syndrome (PSP‐RS). This study investigates whether cognitive deficits predict disease progression in PSP‐RS. METHODS A total of 146 PSP‐RS from the Tilavonemab trial were evaluated at baseline and over 52 weeks using the PSP‐Rating Scale (PSPRS), the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and the Unified Parkinson's Disease Rating Scale Part‐II (UPDRS‐II). Multiple linear regression analyses were performed between the RBANS, UPDRS‐II, and the PSPRS change. Clinical scores, gray matter volumes, and neurofilament‐light chain (NfL) were compared using analyses of covariance (ANCOVAs) and linear mixed models between language score‐groups. RESULTS Lower RBANS‐language at baseline predicted greater PSPRS worsening over time. The low language‐score group showed poorer cognitive performance, elevated NfL, and reduced gray matter volume in language‐related areas. DISCUSSION Speech/language deficits predict worse prognosis in PSP‐RS, emphasizing the value of including language scores in clinical trials. Highlights Speech and language deficits predict a worse prognosis in progressive supranuclear palsy‐Richardson syndrome (PSP‐RS). Lower language scores are associated with worse cognitive performance over time. Lower language scores related to higher neurofilament‐light chain (NfL) at baseline. The low language‐score group presented greater atrophy in language‐related brain areas. Stratifying PSP‐RS cases using language scores may improve clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveLanguage DisordersHumansMaleFemaleDisease ProgressionAgedNeuropsychological TestsNeurofilament ProteinsMiddle AgedMagnetic Resonance ImagingBrainGray Matter

Stichwörter der Autor:innen

PSP‐Rating ScalePSP‐Richardson syndromeRBANScognitiondisease progressiongray matter volumelanguageneurofilament‐light chain

Substanzen

Neurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
  • Movement Disorders Center, Department of Neurology, University of Colorado Anschutz, Aurora, Colorado, USA.
  • Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Institute of Cognitive and Translational Neuroscience (INCyT-INECO-CONICET), Favaloro University Hospital, Buenos Aires, Argentina.
  • Departments of Molecular and Cellular Biology and Statistics, Harvard University, Cambridge, Massachusetts, USA.
  • Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Förderung

  • Marion and Gerald Soloway Chair in Brain Injury and Concussion Research
  • Vivli, Inc
  • UCB
  • American Brain Foundation
  • Sage Therapeutics
  • Alterity
  • Genentech
  • NIH HHS

Zitieren

APA

Garcia-Cordero, I., Vargas-Gonzalez, J. C., Hadian, M., Bayram, E., Rodriguez-Porcel, F., Couto, B., Iyer, J., Golbe, L. I., Stephen, C. D., Pantelyat, A., Dale, M. L., McFarland, N., Xie, T., Swan, M., Kang, K., Gunzler, D., Wills, A. M., Boxer, A., Litvan, I., …, & Tartaglia, M. C. (2025). Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome. Alzheimer's & Dementia, 21(7). https://doi.org/10.1002/alz.70485

Vancouver

Garcia-Cordero I, Vargas-Gonzalez JC, Hadian M, Bayram E, Rodriguez-Porcel F, Couto B, et al. Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome. Alzheimer's & Dementia. 2025;21(7). doi:10.1002/alz.70485

BibTeX
@article{GarciaCordero2025,
  author = {Garcia-Cordero, Indira and Vargas-Gonzalez, Juan Camilo and Hadian, Mohsen and Bayram, Ece and Rodriguez-Porcel, Federico and Couto, Blas and Iyer, Jay and Golbe, Lawrence I and Stephen, Christopher D and Pantelyat, Alexander and Dale, Marian L and McFarland, Nikolaus and Xie, Tao and Swan, Matthew and Kang, Kyurim and Gunzler, Douglas and Wills, Anne-Marie and Boxer, Adam and Litvan, Irene and Lang, Anthony and Tartaglia, Maria Carmela},
  title = {Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {7},
  doi = {10.1002/alz.70485}
}
Kostenlos starten →